Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life.

Francesco Plotti, Gianna Barbara Cundari, Fernando Ficarola, Corrado Terranova, Carlo De Cicco Nardone, Roberto Montera, Daniela Luvero, Federica Guzzo, Adele Silvagni, Amerigo Ferrari, Donatella Caserta, Roberto Angioli
Author Information
  1. Francesco Plotti: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  2. Gianna Barbara Cundari: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  3. Fernando Ficarola: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy. ORCID
  4. Corrado Terranova: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  5. Carlo De Cicco Nardone: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  6. Roberto Montera: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  7. Daniela Luvero: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy. ORCID
  8. Federica Guzzo: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  9. Adele Silvagni: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy. ORCID
  10. Amerigo Ferrari: Division of Obstetrics and Gynaecology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. ORCID
  11. Donatella Caserta: Department of Surgical and Medical Sciences and Translational Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Via di Grottarossa, n. 1035/1039, 00189 Rome, Italy.
  12. Roberto Angioli: Research Unit of Gynaecology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.

Abstract

The efficacy of hyaluronic acid instillations as therapy for patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) has been demonstrated in some clinical studies, with response rates up to 70%. The aim of the study is to investigate the change in symptoms and quality of life in female patients with IC/BPS after intravesical instillations of hyaluronic acid used as first-line treatment. A retrospective single-center cohort study was conducted. Female patients, whose symptoms were compatible with the diagnosis of IC/BPS as defined by the International Continence Society, were treated with a variable number of intravesical instillations of a hyaluronic acid-based drug. Three validated questionnaires were administered by telephone to all patients, before the beginning of the treatment and 6 months after the last administration of the drug. A total of 50 patients with symptoms compatible with the diagnosis of IC/BPS were included in the study. The median number of instillations performed is 4. For all questionnaires, the median value was significantly reduced following treatment with intravesical instillations ( = 0.000). The present study has shown that intravesical hyaluronic acid treatment results in both statistically and clinically significant symptomatic improvement, thereby improving the quality of life of patients with IC/BPS.

Keywords

References

  1. Neurourol Urodyn. 2019 Feb;38(2):535-544 [PMID: 30592544]
  2. J Clin Med. 2022 Sep 26;11(19): [PMID: 36233527]
  3. Transl Androl Urol. 2015 Dec;4(6):638-42 [PMID: 26816865]
  4. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul;19(7):943-7 [PMID: 18338095]
  5. Int J Mol Sci. 2022 Nov 23;23(23): [PMID: 36498919]
  6. Int J Urol. 2020 Jul;27(7):578-589 [PMID: 32291805]
  7. Biologics. 2022 May 20;16:47-55 [PMID: 35619987]
  8. Eur Urol. 2008 Jan;53(1):60-7 [PMID: 17900797]
  9. Ther Adv Urol. 2022 Jun 2;14:17562872221102809 [PMID: 35677571]
  10. Transl Androl Urol. 2017 Jul;6(Suppl 2):S171-S179 [PMID: 28791236]
  11. Taiwan J Obstet Gynecol. 2018 Jun;57(3):360-363 [PMID: 29880165]
  12. BMC Urol. 2024 Apr 24;24(1):95 [PMID: 38658949]
  13. Cells. 2020 Jul 21;9(7): [PMID: 32708202]
  14. Urology. 2001 Jun;57(6 Suppl 1):123 [PMID: 11378112]
  15. Int Urogynecol J. 2011 Apr;22(4):401-5 [PMID: 20938644]
  16. J Sex Med. 2014 Sep;11(9):2256-63 [PMID: 24636240]
  17. Toxins (Basel). 2022 Jan 01;14(1): [PMID: 35051002]
  18. Neurourol Urodyn. 2017 Apr;36(4):984-1008 [PMID: 27564065]
  19. Ther Adv Urol. 2013 Aug;5(4):175-9 [PMID: 23904856]
  20. Urol Int. 1997;59(1):26-9 [PMID: 9313320]
  21. Cell Physiol Biochem. 2016;39(4):1618-25 [PMID: 27627755]
  22. Urology. 1997 May;49(5A Suppl):58-63 [PMID: 9146003]
  23. Urol Int. 2006;76(4):289-95 [PMID: 16679827]
  24. Int J Urol. 2022 Apr;29(4):289-296 [PMID: 34929761]
  25. Int Urogynecol J Pelvic Floor Dysfunct. 2008 May;19(5):717-21 [PMID: 18097627]
  26. Int Urogynecol J. 2012 Dec;23(12):1715-20 [PMID: 22576327]
  27. J Womens Health (Larchmt). 2010 Jun;19(6):1185-93 [PMID: 20491565]
  28. JAMA Netw Open. 2024 Apr 1;7(4):e244880 [PMID: 38587846]
  29. Taiwan J Obstet Gynecol. 2019 May;58(3):417-422 [PMID: 31122535]
  30. J Urol. 2015 May;193(5):1545-53 [PMID: 25623737]
  31. Turk J Urol. 2018 Dec 20;45(2):129-134 [PMID: 30875290]
  32. J Urol. 2005 Jan;173(1):98-102; discussion 102 [PMID: 15592041]

Word Cloud

Created with Highcharts 10.0.0patientshyaluronicinstillationsIC/BPSacidstudyintravesicaltreatmentsymptomsInterstitialCystitis/BladderPainqualitylifecompatiblediagnosisnumberdrugquestionnairesmedianefficacytherapySyndromedemonstratedclinicalstudiesresponserates70%aiminvestigatechangefemaleusedfirst-lineretrospectivesingle-centercohortconductedFemalewhosedefinedInternationalContinenceSocietytreatedvariableacid-basedThreevalidatedadministeredtelephonebeginning6monthslastadministrationtotal50includedperformed4valuesignificantlyreducedfollowing=0000presentshownresultsstatisticallyclinicallysignificantsymptomaticimprovementtherebyimprovingIntravesicalInstillationsHyaluronicAcidFirst-LineTreatmentPatientsSyndrome:UseEfficacyEffectsQualityLifebladderpainsyndromeglycosaminoglycansinterstitialcystitis

Similar Articles

Cited By